📰 **Takeda Ordered To Pay $884.9 Mln In AMITIZA Antitrust Case; To Revise FY25 Results **

(RTTNews) - Takeda Pharmaceutical Co. Ltd. (TAK) said Tuesday a jury in the U.S. District Court for the District of Massachusetts returned a verdict against the company in the AMITIZA or lubiprostone antitrust litigation.

🔗 https://www.nasdaq.com/articles/takeda-ordered-pay-8849-mln-amitiza-antitrust-case-revise-fy25-results

#markets #news